Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer
| Image |  |
|---|---|
| Description | scientific article published on 23 May 2018 |
| Author/s |
author: Philippe L. Bedard Mafalda Oliveira |
| Publication date | May 23, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |